Moreover, many molecularly targeted drugs for psoriasis and AD—TNF, IL-12/IL-23p40 subunit, IL-23p19 subunit, IL-17A, IL-17RA, and IL-4Rα—have been developed. This evidence concerns the gene IL23A and psoriasis.